← Back to all trials
Active Not Recruiting
NCT07178522
A Study to Evaluate the Immunogenicity and Safety of an EV71 Vaccine (Envacgen®) in Children Aged 6 to <10 Years Compared to Children Aged 2 to <6 Years
Conditions: Enterovirus 71 Inactivated Vaccine
Sex: All
Ages: 2 Years – 9 Years
Healthy volunteers: Yes
Phase: PHASE3
Enrollment: 379
Sponsor: Medigen Vaccine Biologics Corp.
Location: National Taiwan University Hospital Hsin-Chu Branch Hsinchu
Summary
The purpose of this study is to assess the immunogenicity and safety of EV71 vaccine (Envacgen®) in Children Aged 6 to \
Eligibility Criteria
Inclusion Criteria:
1. Healthy children aged 2 to \
Source: ClinicalTrials.gov (NCT07178522). StuddyBuddy aggregates publicly available trial information.
